cho_logo_symbol_border
  • (800) 266-7207 | 30 Wall St. 8th Floor New York, NY 10005
  • Mon - Fri: 8:00 am - 5:00 pm

News

Study: Lateral flow tests cannot rule out SARS- CoV-2 infection
Lateral flow devices for asymptomatic mass testing are proving controversial. At the heart of the matter is a flawed process, with
Study: Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection
Acute coronavirus disease 2019 (COVID-19) is primarily diagnosed via reverse transcription-polymerase chain reaction (RT-PCR) detection of viral genetic material. However,
Study: Benefits of Mobile Contact Tracing on COVID-19: Tracing Capacity Perspectives
For effectively suppressing COVID-19's spread, contact tracing has been widely used to identify, isolate, and follow-up with those who have
Study: U.S. Navy’s Response to a Shipboard Coronavirus Outbreak: Considerations for a Medical Management Plan at Sea
The authors observe with interest the ongoing management of the 2019 coronavirus (COVID-19) pandemic and its impact on the U.S.
HPCON: Understanding Health Protection Condition Levels
The Defense Department is taking action around the globe to keep our service members, civilian employees, contractors and their families safe during
More young people are getting hospitalized as a ‘stickier,’ more infectious coronavirus strain becomes dominant
What used to be a mysterious new variant first detected in the UK is now the most dominant coronavirus strain in
Article: The tragedy of long COVID
Tens of thousands of people in the United States have lingering illness following COVID-19. In the US, we call them
Study: An interactive web-based dashboard to track COVID-19 in real time
In response to COVID-19 ongoing public health emergency, we developed an online interactive dashboard, hosted by the Center for Systems
Study: Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Numerous variants of SARS-CoV-2-harboring mutations in spike have arisen globally mRNA vaccines elicit potent neutralizing activity against homologous pseudovirus
Study: SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
SARS-CoV-2 entry is mediated by the spike (S) glycoprotein which contains the receptor-binding domain (RBD) and the N-terminal domain (NTD)

Disclaimer

Clear Health Pass Safe Harbor Exemption
The information on this website does not constitute an offer to sell or solicitation of an offer to buy securities by anyone in any jurisdiction which would be considered unlawful. Clear Health Pass Holdings, LLC’s offering is under Rule 506(c) of Regulation D and is considered a “safe harbor” for the private offering exemption of Section 4(a)(2) of the Securities Act. To be eligible to receive qualified investment status, you must be an accredited investor as defined by Section 2(15)(ii) of the Securities Act of 1933.

© 2023 Clear Health Pass Holdings™, LLC., All trademark references are trademarks of either the Clear Health Pass Holdings, LLC or their respective owners.

 

Our Journey to $1B+ Valuation

 

Disrupting Healthcare Testing / Diagnostics Early Detection of Cancer,
Chronic Conditions, Disease, Unlocking Anti-Aging Genomics & Promoting Longevity.

 

FUNDING GOAL $20,000,000

Funding Goal $20,000,000

20%

Click here to Download Our Investment Package

Skip to content